Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

CROI 2017: Neurologic Complications of HIV Infection.

Spudich SS, Ances BM.

Top Antivir Med. 2017 May/Jun;25(2):69-76.

2.

CROI 2016: Neurologic Complications of HIV Infection.

Spudich SS, Ances BM.

Top Antivir Med. 2016 May-Jun;24(1):29-37. Review.

3.

CROI 2015: Neurologic Complications of HIV Infection.

Spudich SS, Ances BM.

Top Antivir Med. 2015 Mar-Apr;23(1):47-55.

4.

CROI 2014: Neurologic complications of HIV infection.

Spudich SS.

Top Antivir Med. 2014 May;22(2):594-601. Review.

5.

Neurologic complications of HIV infection.

Spudich SS, Ances BM.

Top Antivir Med. 2012 Jun-Jul;20(2):41-7. Review.

6.

Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.

Matinella A, Lanzafame M, Bonometti MA, Gajofatto A, Concia E, Vento S, Monaco S, Ferrari S.

J Neurol. 2015 May;262(5):1317-27. doi: 10.1007/s00415-015-7713-8. Epub 2015 Apr 1.

PMID:
25877836
7.
8.

Antiretroviral treatment of central nervous system HIV-1 infection: a review.

Gisslén M, Hagberg L.

HIV Med. 2001 Apr;2(2):97-104. Review.

9.

Immune activation in the central nervous system throughout the course of HIV infection.

Spudich SS.

Curr Opin HIV AIDS. 2016 Mar;11(2):226-33. doi: 10.1097/COH.0000000000000243. Review.

10.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
11.
12.

Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.

Sánchez-Ramón S, Bellón JM, Resino S, Cantó-Nogués C, Gurbindo D, Ramos JT, Muñoz-Fernández MA.

Pediatrics. 2003 Feb;111(2):E168-75.

PMID:
12563091
13.

Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.

Buzon MJ, Martin-Gayo E, Pereyra F, Ouyang Z, Sun H, Li JZ, Piovoso M, Shaw A, Dalmau J, Zangger N, Martinez-Picado J, Zurakowski R, Yu XG, Telenti A, Walker BD, Rosenberg ES, Lichterfeld M.

J Virol. 2014 Sep 1;88(17):10056-65. doi: 10.1128/JVI.01046-14. Epub 2014 Jun 25.

14.
15.

Neurologic complications of HIV disease and their treatment.

Letendre SL, Ellis RJ, Ances BM, McCutchan JA.

Top HIV Med. 2010 Apr-May;18(2):45-55. Review.

16.

Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy.

Kranick SM, Nath A.

Continuum (Minneap Minn). 2012 Dec;18(6 Infectious Disease):1319-37. doi: 10.1212/01.CON.0000423849.24900.ec. Review.

17.

Neurologic complications of HIV disease and their treatments.

Letendre S, Ellis RJ.

Top HIV Med. 2006 Mar-Apr;14(1):21-6.

18.

Alarmins and central nervous system inflammation in HIV-associated neurological disorders.

Gougeon ML.

J Intern Med. 2017 May;281(5):433-447. doi: 10.1111/joim.12570. Epub 2016 Nov 16. Review.

PMID:
27862491
19.

HIV-associated neurological disorders: a guide to pharmacotherapy.

Tan IL, McArthur JC.

CNS Drugs. 2012 Feb 1;26(2):123-34. doi: 10.2165/11597770-000000000-00000. Review.

PMID:
22201342
20.

Molecular analysis of cerebrospinal fluid: potential for the study of HIV-1 infection of the central nervous system.

Cinque P, Bestetti A, Morelli P, Presi S.

J Neurovirol. 2000 May;6 Suppl 1:S95-S102. Review.

PMID:
10871772

Supplemental Content

Support Center